Opinion on adventitious agents testing for vaccines: why do we worry so much about adventitious agents in vaccines?

Area of Science:

• Vaccinology
• Microbial Contamination Control
• Biopharmaceutical Manufacturing

Background:

• Viral vaccines produced in biological systems are susceptible to microbial contamination.
• Significant resources are dedicated to preventing and detecting contamination.
• The scientific validity and efficiency of current practices warrant re-evaluation.

Purpose of the Study:

• To discuss the historical context and rationale behind current contamination control strategies in viral vaccine production.
• To propose alternative or supplementary methods, including new technologies.
• To advocate for a shift towards more scientific and rational approaches to ensure vaccine safety and purity.

Main Methods:

• Review of traditional in vivo methods for viral vaccine production.
• Discussion of the 3 R's policy (Replacement, Reduction, Refinement) in the context of animal testing.
• Advocacy for a risk-based approach aligned with Quality by Design principles.

Main Results:

• Current contamination control efforts require critical assessment for efficiency and scientific soundness.
• Traditional in vivo methods may be re-examined in light of the 3 R's policy.
• A Quality by Design framework offers a more rational basis for managing contamination risks.

Conclusions:

• Vaccinologists must ensure public confidence by guaranteeing vaccine safety and purity.
• Implementing a risk-based approach and potentially novel strategies can enhance contamination control.
• Continuous re-evaluation of production and safety protocols is essential for safeguarding public health.